Trial Profile
A trial to assess plerixafor in combination with granulocyte colony stimulating factors, versus granulocyte colony stimulating factors alone, for stem cell mobilisation in patients with multiple myeloma and non-Hodgkin's lymphoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2014
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 09 Oct 2014 New trial record